• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用羧酸抑制结核分枝杆菌的β 类碳酸酐酶。

Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.

机构信息

Università degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, Sesto Fiorentino (Florence), Italy.

出版信息

J Enzyme Inhib Med Chem. 2013 Apr;28(2):392-6. doi: 10.3109/14756366.2011.650168. Epub 2012 Feb 3.

DOI:10.3109/14756366.2011.650168
PMID:22299588
Abstract

The growth of Mycobacterium tuberculosis is strongly inhibited by weak acids although the mechanism by which these compounds act is not completely understood. A series of substituted benzoic acids, nipecotic acid, ortho- and para-coumaric acid, caffeic acid and ferulic acid were investigated as inhibitors of three β-class carbonic anhydrases (CAs, EC 4.2.1.1) from this pathogen, mtCA 1 (Rv1284), mtCA 2 (Rv3588c) and mtCA 3 (Rv3273). All three enzymes were inhibited with efficacies between the submicromolar to the micromolar one, depending on the scaffold present in the carboxylic acid. mtCA 3 was the isoform mostly inhibited by these compounds (K(I)s in the range of 0.11-0.97 µM); followed by mtCA 2 (K(I)s in the range of 0.59-8.10 µM), whereas against mtCA 1, these carboxylic acids showed inhibition constants in the range of 2.25-7.13 µM. This class of relatively underexplored β-CA inhibitors warrant further in vivo studies, as they may have the potential for developing antimycobacterial agents with a diverse mechanism of action compared to the clinically used drugs for which many strains exhibit multi-drug or extensive multi-drug resistance.

摘要

尽管这些化合物的作用机制尚未完全阐明,但弱酸性物质强烈抑制结核分枝杆菌的生长。一系列取代的苯甲酸、尼克酸、邻-和对香豆酸、咖啡酸和阿魏酸被用作该病原体三种β类碳酸酐酶(CA,EC 4.2.1.1)的抑制剂进行研究,分别是 mtCA 1(Rv1284)、mtCA 2(Rv3588c)和 mtCA 3(Rv3273)。根据羧酸中存在的支架,所有三种酶的抑制效率在亚毫摩尔到毫摩尔之间。mtCA 3 是最易受这些化合物抑制的同工酶(K(I)值在 0.11-0.97 μM 范围内);其次是 mtCA 2(K(I)值在 0.59-8.10 μM 范围内),而对于 mtCA 1,这些羧酸的抑制常数范围在 2.25-7.13 μM 之间。与临床使用的药物相比,这类相对较少研究的β-CA 抑制剂具有不同的作用机制,因此可能有潜力开发出抗分枝杆菌药物,而许多菌株对这些药物表现出多药耐药或广泛的多药耐药性。

相似文献

1
Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.用羧酸抑制结核分枝杆菌的β 类碳酸酐酶。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):392-6. doi: 10.3109/14756366.2011.650168. Epub 2012 Feb 3.
2
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.二硫代氨基甲酸盐强烈抑制分枝杆菌属结核分枝杆菌的β级碳酸酐酶。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):407-11. doi: 10.3109/14756366.2011.641015. Epub 2011 Dec 6.
3
Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis.二卤代磺胺和苯甲酰胺类是结核分枝杆菌三种β类碳酸酐酶的有效抑制剂。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):384-7. doi: 10.3109/14756366.2011.645539. Epub 2012 Jan 3.
4
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.碳酸酐酶抑制剂。结核分枝杆菌Rv3588c中最具活性的β-碳酸酐酶的特性及抑制研究。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6649-54. doi: 10.1016/j.bmcl.2009.10.009. Epub 2009 Oct 7.
5
The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.结核分枝杆菌β-碳酸酐酶作为药物靶点。
Curr Pharm Des. 2010;16(29):3300-9. doi: 10.2174/138161210793429814.
6
Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.碳酸酐酶抑制剂。用重氮基苯磺酰胺抑制结核分枝杆菌的Rv1284和Rv3273β-碳酸酐酶。
Bioorg Med Chem Lett. 2009 Sep 1;19(17):4929-32. doi: 10.1016/j.bmcl.2009.07.088. Epub 2009 Jul 22.
7
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.碳酸酐酶抑制剂。结核分枝杆菌一种新型β-碳酸酐酶的克隆、表征及抑制研究。
J Med Chem. 2009 May 14;52(9):3116-20. doi: 10.1021/jm9003126.
8
Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.结核分枝杆菌Rv1284β-碳酸酐酶的分子克隆、特性鉴定以及用磺胺类药物和氨基磺酸盐进行的抑制研究
J Med Chem. 2009 Apr 23;52(8):2226-32. doi: 10.1021/jm9000488.
9
Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors.α 类细胞溶质人碳酸酐酶 I、II、IX 和 XII 以及β 类真菌酶的抑制作用:新型同工酶 I 选择性纳摩尔抑制剂。
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5801-6. doi: 10.1016/j.bmcl.2012.07.094. Epub 2012 Aug 2.
10
Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.甲硝唑-香豆素缀合物和 3-氰基-7-羟基香豆素可作为同工型选择性碳酸酐酶抑制剂。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):397-401. doi: 10.3109/14756366.2011.650692. Epub 2012 Feb 3.

引用本文的文献

1
Carbonic anhydrase, its inhibitors and vascular function.碳酸酐酶、其抑制剂与血管功能。
Front Mol Biosci. 2024 Jan 29;11:1338528. doi: 10.3389/fmolb.2024.1338528. eCollection 2024.
2
Boulton-Katritzky Rearrangement of 5-Substituted Phenyl-3-[2-(morpholin-1-yl)ethyl]-1,2,4-oxadiazoles as a Synthetic Path to Spiropyrazoline Benzoates and Chloride with Antitubercular Properties.5-取代苯基-3-[2-(吗啉-1-基)乙基]-1,2,4-噁二唑的Boulton-Katritzky 重排反应:作为具有抗结核性质的螺吡喃并苯甲酸盐和氯化物的合成途径。
Molecules. 2021 Feb 12;26(4):967. doi: 10.3390/molecules26040967.
3
Blutaparon portulacoides ethanolic extract reduced IL-1β and inflammatory parameters induced by the Mycobacterium complex and carrageenan in mice.
马齿苋乙醇提取物可降低由分枝杆菌复合体和角叉菜胶诱导的小鼠的 IL-1β 和炎症参数。
Inflammopharmacology. 2021 Apr;29(2):439-450. doi: 10.1007/s10787-020-00752-0. Epub 2020 Sep 10.
4
Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety.新型 7-氨基-3,4-二氢喹啉-2(1H)-酮衍生物的制备、碳酸酐酶抑制和抗氧化活性,其中包含单肽或二肽部分。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1021-1026. doi: 10.1080/14756366.2020.1751620.
5
Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids.筛选靶向结核分枝杆菌谷氨酸 racemase 的天然化合物,揭示了黄酮类化合物的抗结核潜力。
Sci Rep. 2020 Jan 22;10(1):949. doi: 10.1038/s41598-020-57658-8.
6
Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates.新型氨基酸-磺胺缀合物的合成及其对人碳酸酐酶 I、II、VA 和 XII 的抑制作用。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):489-497. doi: 10.1080/14756366.2019.1710503.
7
inhibition of -carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos.用单硫代和二硫代氨基甲酸盐抑制 -碳酸酐酶 3 及其对斑马鱼胚胎发育毒性的评估。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):65-71. doi: 10.1080/14756366.2019.1683007.
8
-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.碳酸酐酶:抗结核药物研发的新靶点。
Int J Mol Sci. 2019 Oct 17;20(20):5153. doi: 10.3390/ijms20205153.
9
Synthesis carbonic anhydrase enzyme inhibition and antioxidant activity of novel benzothiazole derivatives incorporating glycine, methionine, alanine, and phenylalanine moieties.合成含甘氨酸、蛋氨酸、丙氨酸和苯丙氨酸片段的新型苯并噻唑衍生物的碳酸酐酶抑制和抗氧化活性。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):343-349. doi: 10.1080/14756366.2018.1553040.
10
Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on and Studies.碳酸酐酶抑制剂作为抗分枝杆菌β-碳酸酐酶的新型药物:研究进展。
Molecules. 2018 Nov 8;23(11):2911. doi: 10.3390/molecules23112911.